SCHEMBL30264706

SCHEMBL30264706

COC(=O)c1ncnc2cc(OC)c(O)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.52
EGFR P00533 6/20 0.50
RET P07949 9/20 0.47
KDR P35968 9/20 0.47
KIF5B P33176 7/20 0.47
AURKB Q96GD4 2/20 0.45
JAK3 P52333 2/20 0.44
MKNK1 Q9BUB5 1/20 0.44
AURKA O14965 1/20 0.44
PDGFRB P09619 1/20 0.43
GAK O14976 1/20 0.43
RIPK2 O43353 1/20 0.43
STK10 O94804 1/20 0.43
FLT3 P36888 1/20 0.43
AAK1 Q2M2I8 1/20 0.43
Q6ZSR9 Q6ZSR9 1/20 0.43
SLK Q9H2G2 1/20 0.43
IRAK4 Q9NWZ3 1/20 0.43
RPS6KA6 Q9UK32 1/20 0.43
ALK Q9UM73 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28055083 0.78 PDE10A (0.73) PDE10AEGFRRETKDRKIF5B
SCHEMBL216888 0.78 EGFR (0.53) EGFRRETKDRKIF5BJAK3
SCHEMBL29801726 0.78 EGFR (0.53) EGFRRETKDRKIF5BJAK3
SCHEMBL20813476 0.76 EGFR (0.52) EGFRRETKDRKIF5BJAK3
Hydrochloric Acid SCHEMBL28006468 0.76 EGFR (0.52) EGFRRETKDRKIF5BJAK3
SCHEMBL12447316 0.76 EGFR (0.52) EGFRRETKDRKIF5BJAK3
SCHEMBL29249689 0.76 GABRP (0.45) PDE10AEGFRRETKDRKIF5B
Acetic Acid SCHEMBL3170544 0.75 ENPP1 (0.56) PDE10AEGFRRETKDRKIF5B
SCHEMBL8230611 0.75 EGFR (0.51) EGFRRETKDRKIF5BJAK3
SCHEMBL30032092 0.75 ENPP1 (0.63) EGFRRETKDRKIF5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4392423-A1 QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE Arthrosi Therapeutics, Inc. (US) 2024-07-03 EP disclosed
WO-2023028054-A1 QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE ARTHROSI THERAPEUTICS, INC. (US) 2023-03-02 WO disclosed